Der fandtes ingen systemisk akkumulation når ibandronsyre blev indgivet intravenøst én gang hver 4. uge i 48 uger til patienter med metastaserende knoglesygdom.
No systemic accumulation was observed when ibandronic acid was administered intravenously once every 4 weeks for 48 weeks to patients with metastatic bone disease.